MetaCap

Innoviva (INVA) vs Nanobiotix S.A. (NBTX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Nanobiotix S.A. (NBTX) has outperformed Innoviva (INVA) over the past year, gaining 26.6% versus a loss of 12.2%. Over five years, NBTX leads with a +214.0% price change compared with +8.8% for INVA. Nanobiotix S.A. is the larger company by market cap ($1.35 billion vs $1.31 billion), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

INVA-12.17%NBTX+26.61%
+172%+75%-21%
Nov 21, 20251 yearNov 20, 2026
INVA+7.98%NBTX+185.87%
+482%+189%-104%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

INVA versus NBTX key metrics
MetricINVANBTX
Share price$18.41$26.50
Market cap$1.31B$1.35B
1-day change0.00%-2.98%
YTD return-7.90%+14.62%
1-year return-12.17%+26.61%
5-year return+8.81%+213.98%
P/E ratio (TTM)7.83—
Forward P/E8.33—
EPS (TTM)$2.35$-1.27
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$411.33M—
Revenue growth (YoY)+14.67%—
Net income (latest FY)$271.17M—
Gross margin74.80%—
Operating margin39.81%—
Net margin65.92%—
52-week high$25.15$57.14
52-week low$18.19$19.14
Distance from 52-week high-26.80%-53.62%
Analyst consensusbuynone
Avg. price target upside+89.03%+101.06%
Average volume865.66K148.94K
Shares outstanding71.08M50.95M
Employees15998
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • NBTX has outperformed INVA by 38.8 percentage points over the past year.

About Innoviva

INVA stock →

Innoviva, Inc. operates as a biopharmaceutical company in the United States and internationally.

Health Care · Biotechnology: Pharmaceutical Preparations · 159 employees

About Nanobiotix S.A.

NBTX stock →

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs.

Health Care · Biotechnology: Pharmaceutical Preparations · 98 employees

INVA vs NBTX FAQ

Which is bigger, Innoviva or Nanobiotix S.A.?

Nanobiotix S.A. (NBTX) is larger, with a market capitalization of $1.35B compared with $1.31B for Innoviva (INVA).

Which stock has performed better over the past year, INVA or NBTX?

NBTX returned +26.61% over the past 12 months, compared with -12.17% for INVA (price return, excluding dividends). Past performance does not predict future results.

Are Innoviva and Nanobiotix S.A. in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons